We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$12.8B
AUM Growth
+$1.36B
Cap. Flow
+$773M
Cap. Flow %
6.06%
Top 10 Hldgs %
12.57%
Holding
2,812
New
294
Increased
855
Reduced
703
Closed
290

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$28.3M
2
HAL icon
Halliburton
HAL
+$24.2M
3
EA icon
Electronic Arts
EA
+$23.9M
4
ICON
Iconix Brand Group, Inc.
ICON
+$23.7M
5
HELE icon
Helen of Troy
HELE
+$20.4M

Sector Composition

Rank Sector Weight
1 Technology 14.92%
2 Healthcare 14.07%
3 Industrials 12.64%
4 Financials 10.64%
5 Consumer Discretionary 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
26
RTX Corp
RTX
$287B
$74.9M 0.59%
1,035,534
-19,039
-2% -$1.3M
AMGN icon
27
Amgen
AMGN
$203B
$73M 0.57%
458,306
+41,533
+10% +$6.47M
ABT icon
28
Abbott
ABT
$180B
$72.8M 0.57%
1,616,325
-26,463
-2% -$1.15M
MRK icon
29
Merck
MRK
$324B
$68.3M 0.54%
1,260,500
+2,795
+0.2% +$156K
AXP icon
30
American Express
AXP
$223B
$67.9M 0.53%
729,857
+16,226
+2% +$1.45M
HON icon
31
Honeywell
HON
$77B
$67.9M 0.53%
756,036
+82,397
+12% +$7.09M
LLY icon
32
Eli Lilly
LLY
$1.07T
$63.5M 0.5%
920,197
-14,170
-2% -$956K
VIG icon
33
Vanguard Dividend Appreciation ETF
VIG
$111B
$62.8M 0.49%
773,320
+56,056
+8% +$4.43M
AGN
34
DELISTED
Allergan Inc
AGN
$61.7M 0.48%
290,258
-39,885
-12% -$7.93M
ACN icon
35
Accenture
ACN
$89.9B
$61M 0.48%
682,529
-192,001
-22% -$15.9M
T icon
36
AT&T
T
$165B
$60.9M 0.48%
2,399,068
+98,846
+4% +$2.56M
CL icon
37
Colgate-Palmolive
CL
$72.6B
$59.5M 0.47%
859,327
-7,598
-0.9% -$513K
USCI icon
38
US Commodity Index
USCI
$372M
$57.9M 0.45%
1,199,286
-45,336
-4% -$2.4M
USB icon
39
US Bancorp
USB
$99.6B
$56.9M 0.45%
1,266,746
-16,582
-1% -$714K
PH icon
40
Parker-Hannifin
PH
$125B
$55.8M 0.44%
432,502
+139,105
+47% +$17.1M
SWKS icon
41
Skyworks Solutions
SWKS
$9.06B
$55.3M 0.43%
761,178
-15,144
-2% -$939K
CTSH icon
42
Cognizant
CTSH
$21.5B
$53.5M 0.42%
1,016,617
+193,383
+23% +$9.66M
LH icon
43
Labcorp
LH
$24.3B
$52.5M 0.41%
566,578
+320,621
+130% +$28.3M
EMR icon
44
Emerson Electric
EMR
$82.9B
$52.5M 0.41%
850,143
-58,517
-6% -$3.67M
OMC icon
45
Omnicom Group
OMC
$22.7B
$50.3M 0.39%
648,738
+39,787
+7% +$2.9M
VZ icon
46
Verizon
VZ
$194B
$49.1M 0.39%
1,050,657
+210,425
+25% +$10.3M
BEN icon
47
Franklin Resources
BEN
$16.9B
$48M 0.38%
866,843
-30,578
-3% -$1.69M
MMS icon
48
Maximus
MMS
$3.14B
$47.6M 0.37%
867,453
+132,496
+18% +$6.44M
PNC icon
49
PNC Financial Services
PNC
$100B
$47.2M 0.37%
517,718
-1,105
-0.2% -$95.8K
BAX icon
50
Baxter International
BAX
$11.6B
$46.4M 0.36%
1,165,931
-194,331
-14% -$7.57M

Similar funds

Glenmede Trust's Q4 2014 Portfolio in Review

As of Q4 2014, Glenmede Trust held 2,812 positions worth $12.8B, up 12% from $11.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust deployed $773M of net new capital in Q4 2014, opening 294 new positions and adding to 855 existing holdings. Its largest new stake was Portland General Electric: 447,386 shares worth $16.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was eBay, an estimated $18.8M trimmed.

  • Glenmede Trust's largest Q4 2014 buy was Portland General Electric: 447,386 shares worth $16.9M.
  • Glenmede Trust added most to Labcorp in Q4 2014, an estimated $28.3M increase.
  • Glenmede Trust's biggest Q4 2014 reduction was eBay, cutting an estimated $18.8M.
  • Glenmede Trust fully exited SAPIENT CORP in Q4 2014, selling an estimated $16.9M.
  • Glenmede Trust's ten largest holdings make up 13% of its $12.8B portfolio in Q4 2014.
  • Glenmede Trust opened 294 new positions and closed 290 in Q4 2014.
  • Glenmede Trust's portfolio value rose 12% quarter-over-quarter to $12.8B.

Based on Glenmede Trust's 13F filing for Q4 2014, filed 6 Feb 2015.